The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Background Despite the number of medications for type 2 diabetes, many people with the condition do not achieve good glycaemic control. Some existing glucose-lowering agents have adverse effects such ...

Next‑Gen Amnio-Chorionic Membrane for Enhanced Wound Care is Latest Offering in a Slew of New Products Focused on Increasing ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to a new study. Although its efficacy hasn't yet been tested in humans, the ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Since diabetes was identified as a disease, researchers continue to discover new medications to effectively manage diabetes. On December 21, 2017, the U.S. Food and Drug Administration (FDA) approved ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Objectives To evaluate the effect of pioglitazone in people with insulin resistance, pre-diabetes and type 2 diabetes. Design and setting Systematic review and meta-analysis of randomised, controlled ...

A large real-world Italian cohort study found that daily low-dose aspirin use significantly lowered the risk of developing ...